0.5% Bupivacaine HCl

DRUG4 trials

Sponsors

Pacira Pharmaceuticals, Inc, NYU Langone Health, HCA Florida North Florida Hospital, The University of Texas Health Science Center at San Antonio

Conditions

HeadacheMigraineOccipital NeuralgiaPeriodontal SurgeryPostoperative Pain ManagementShoulder PainTension Headache

Phase 1

The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal Surgical Procedures

CompletedNCT07725731

The University of Texas Health Science Center at San AntonioPeriodontal Surgery

Start: 2024-10-02End: 2026-06-02Updated: 2026-07-27

Phase 3

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

CompletedNCT03682302

Pacira Pharmaceuticals, IncPostoperative Pain Management

Start: 2019-04-02End: 2019-09-24Updated: 2021-01-06

0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment

Not yet recruitingNCT06937385

HCA Florida North Florida HospitalHeadache, Migraine, Tension Headache +1

Start: 2025-05-01End: 2026-05-01Target: 100Updated: 2025-04-24

Phase 4

Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA)

CompletedNCT03913091

NYU Langone HealthShoulder Pain

Start: 2019-03-01End: 2021-01-19Updated: 2022-02-01

Related Papers

A multicenter study to evaluate the pharmacokinetics and safety of liposomal bupivacaine for postsurgical analgesia in pediatric patients aged 6 to less than 17 years (PLAY).

2021-09-1421 citations